Thymmune Therapeutics
Signal active
Organization
Contact Information
Overview
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
About
Industries
Biotechnology, Therapeutics
Founded
2019
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Thymmune Therapeutics headquartered in United States, North America, operates in the Biotechnology, Therapeutics sector. The company focuses on Biotechnology and has secured $704.0M in funding across 16 round(s). With a team of 1-10 employees, Thymmune Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Thymmune Therapeutics, raised $37.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$44.0M
Details
1
Thymmune Therapeutics has raised a total of $44.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 7.0M |
Investors
Thymmune Therapeutics is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Thymmune Therapeutics | - | FUNDING ROUND - Thymmune Therapeutics | 7.0M |
| Arranta Bio | - | FUNDING ROUND - Arranta Bio | 7.0M |
| Thymmune Therapeutics | - | FUNDING ROUND - Thymmune Therapeutics | 37.0M |
| Advanced Research Projects Agency for Health | - | FUNDING ROUND - Advanced Research Projects Agency for Health | 37.0M |
Recent Activity
There is no recent news or activity for this profile.